{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T01:44:59Z","timestamp":1782697499086,"version":"3.54.5"},"reference-count":149,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The role of gut microbiota and intestinal dysbiosis in promoting inflammaging in chronic kidney disease (CKD) has been the focus of intense research over the last years. Some alterations at the phyla level, such as abundance of Proteobacteria and reduction in Firmicutes\/Bacteroidites (F\/B) ratio and saccarolytic populations, have been consistently reported in CKD. Other mechanisms include microbial translocation through a \u201cleaky gut\u201d and subsequent molecular mimicry, immune dysregulation (unbalance between T reg and Th17 subsets), and epigenetic interactions. Alterations of metabolic pathways and of bacterial metabolites, such as butyrate and other short chain fatty acids (SCFA), also appear to play a key role in modulating progression of CKD. On the other hand, microbiota-based therapy appears promising and includes diet, prebiotics, probiotics, synbiotics, postbiotics and fecal microbiota transplantation (FMT). Modulation of microbiota could correct critical alterations, such as F\/B ratio and T reg\/Th17 unbalance, blunting inflammaging and potentially reducing progression of CKD and cardiovascular disease. Despite current limitations, gut microbiota is emerging as a powerful environmental factor which could be harnessed to interfere with key mechanisms leading to inflammaging in CKD.<\/jats:p>","DOI":"10.3390\/cells15131171","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:54:42Z","timestamp":1782694482000},"page":"1171","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut Microbiota Dysbiosis Is a Key Driver of Inflammaging in Chronic Kidney Disease"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7365-7287","authenticated-orcid":false,"given":"Emanuele","family":"Parodi","sequence":"first","affiliation":[{"name":"Nephrology and Dialysis Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Mario","family":"Castello","sequence":"additional","affiliation":[{"name":"Internal Medicine Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy"},{"name":"Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale (UPO), 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-5729","authenticated-orcid":false,"given":"Paolo","family":"Bottino","sequence":"additional","affiliation":[{"name":"Microbiology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2200-2674","authenticated-orcid":false,"given":"Franca","family":"Gotta","sequence":"additional","affiliation":[{"name":"Microbiology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialuisa","family":"Novi","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Orsello","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6259-5295","authenticated-orcid":false,"given":"Andrea","family":"Rocchetti","sequence":"additional","affiliation":[{"name":"Microbiology Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Prenna","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale (UPO), 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4120-3555","authenticated-orcid":false,"given":"Vincenzo","family":"Cantaluppi","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale (UPO), 28100 Novara, Italy"},{"name":"Nephrology and Transplant Unit, Maggiore della Carita University Hospital, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-9255","authenticated-orcid":false,"given":"Marco","family":"Quaglia","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, SS. Antonio e Biagio e Cesare Arrigo University Hospital, 15121 Alessandria, Italy"},{"name":"Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale (UPO), 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Qin, K., Qing, J., Wang, Q., and Li, Y. (2024). Epidemiological Shifts in Chronic Kidney Disease: A 30-Year Global and Regional Assessment. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-21065-9"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Jiang, B., Dong, Y., Xiong, Y., Jiang, C., Ping, J., Wu, Q., Xu, L., Shu, R., Gao, D., and Zhu, S. (2025). Global Research Trends in Inflammaging from 2005 to 2024: A Bibliometric Analysis. Front. Aging, 6.","DOI":"10.3389\/fragi.2025.1554186"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00109-022-02234-y","article-title":"Uremic Mouse Model to Study Vascular Calcification and \u201cInflamm-Aging\u201d","volume":"100","author":"Henkel","year":"2022","journal-title":"J. Mol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Caturano, A., Galiero, R., Rocco, M., Tagliaferri, G., Piacevole, A., Nilo, D., Di Lorenzo, G., Sardu, C., Russo, V., and Vetrano, E. (2024). The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease. Biomolecules, 14.","DOI":"10.3390\/biom14111393"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/imj.15759","article-title":"Frailty in Chronic Kidney Disease: Challenges in Nephrology Practice. A Review of Current Literature","volume":"53","author":"Kennard","year":"2023","journal-title":"Intern. Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e13787","DOI":"10.1002\/jcsm.13787","article-title":"Osteosarcopenia in Chronic Kidney Disease: An Overlooked Syndrome?","volume":"16","author":"Caldiroli","year":"2025","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41581-025-00963-0","article-title":"Drivers and Mechanisms of Cognitive Decline in Chronic Kidney Disease","volume":"21","author":"Capasso","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jimmun\/vkae036","article-title":"Immunological Biomarkers of Aging","volume":"214","author":"Wu","year":"2025","journal-title":"J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Picca, A., Lezza, A., Leeuwenburgh, C., Pesce, V., Calvani, R., Landi, F., Bernabei, R., and Marzetti, E. (2017). Fueling Inflamm-Aging through Mitochondrial Dysfunction: Mechanisms and Molecular Targets. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050933"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Theodorakis, N., Feretzakis, G., Hitas, C., Kreouzi, M., Kalantzi, S., Spyridaki, A., Kollia, Z., Verykios, V.S., and Nikolaou, M. (2024). Immunosenescence: How Aging Increases Susceptibility to Bacterial Infections and Virulence Factors. Microorganisms, 12.","DOI":"10.3390\/microorganisms12102052"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Scheithauer, T.P.M., Rampanelli, E., Nieuwdorp, M., Vallance, B.A., Verchere, C.B., Van Raalte, D.H., and Herrema, H. (2020). Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.571731"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1111\/febs.16558","article-title":"The Intestinal Immune System and Gut Barrier Function in Obesity and Ageing","volume":"290","author":"Shemtov","year":"2023","journal-title":"FEBS J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s42255-021-00348-0","article-title":"Gut Microbiome Pattern Reflects Healthy Ageing and Predicts Survival in Humans","volume":"3","author":"Wilmanski","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41367-020-0017-1","article-title":"Obesity Programs of Nutrition, Education, Research and Assessment (OPERA) Group. From Obesity through Gut Microbiota to Cardiovascular Diseases: A Dangerous Journey","volume":"10","author":"Marzullo","year":"2020","journal-title":"Int. J. Obes. Suppl."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11894-025-00973-9","article-title":"The Neuroimmune Axis in Gastrointestinal Disorders\u2014An Underrecognized Problem","volume":"27","author":"Pace","year":"2025","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2501024","DOI":"10.4014\/jmb.2501.01024","article-title":"Microbiome, Potential Therapeutic Agents: New Players of Obesity Treatment","volume":"35","author":"Ali","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"M\u00fcnte, E., and Hartmann, P. (2025). The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases. Biomolecules, 15.","DOI":"10.3390\/biom15040469"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Fu, L., Baranova, A., Cao, H., and Zhang, F. (2025). Gut Microbiome Links Obesity to Type 2 Diabetes: Insights from Mendelian Randomization. BMC Microbiol., 25.","DOI":"10.1186\/s12866-025-03968-8"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coemr.2020.06.005","article-title":"Metabolic and Inflammatory Functions of Short-Chain Fatty Acid Receptors","volume":"16","author":"Bolognini","year":"2021","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00184-23","DOI":"10.1128\/mmbr.00184-23","article-title":"Vitamin Biosynthesis in the Gut: Interplay between Mammalian Host and Its Resident Microbiota","volume":"89","author":"Tarracchini","year":"2025","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00281-025-01049-6","article-title":"Microbiota-Dependent Modulation of Intestinal Anti-Inflammatory CD4+ T Cell Responses","volume":"47","author":"Edwards","year":"2025","journal-title":"Semin. Immunopathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9367404","DOI":"10.1155\/2019\/9367404","article-title":"The Interplay between Immune System and Microbiota in Diabetes","volume":"2019","author":"Moffa","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_23","first-page":"e81447","article-title":"Gut Microbiota and Mental Health: A Comprehensive Review of Gut-Brain Interactions in Mood Disorders","volume":"17","author":"Mehta","year":"2025","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"167862","DOI":"10.1016\/j.bbadis.2025.167862","article-title":"Parkinson\u2019s Disease and Gut Microbiota Metabolites: The Dual Impact of Vitamins and Functional Amyloids","volume":"1871","author":"Mirab","year":"2025","journal-title":"Biochim. Biophys. Acta BBA\u2014Mol. Basis Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15481","DOI":"10.1038\/s41598-025-00237-6","article-title":"Characterization of Gut Dysbiosis and Intestinal Barrier Dysfunction in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Chronic Kidney Disease: A Comparative Study","volume":"15","author":"Dissayabutra","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s13679-025-00624-0","article-title":"A Cascade of Microbiota-Leaky Gut-Inflammation- Is It a Key Player in Metabolic Disorders?","volume":"14","author":"Mishra","year":"2025","journal-title":"Curr. Obes. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.immuni.2025.05.016","article-title":"ILC3s Sense Gut Microbiota through STING to Initiate Immune Tolerance","volume":"58","author":"Zhou","year":"2025","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2516702","DOI":"10.1080\/19490976.2025.2516702","article-title":"Gut Microbiota in Regulatory T Cell Generation and Function: Mechanisms and Health Implications","volume":"17","author":"Sharma","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cgh.2018.08.067","article-title":"Influence of Early Life, Diet, and the Environment on the Microbiome","volume":"17","author":"Dong","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Laterza, L., Cremon, C., Coppola, G., Settanni, C.R., Maresca, R., Strazzeri, M., Durini, E., Petito, V., Scaldaferri, F., and Gargari, G. (2025). Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial. Nutrients, 17.","DOI":"10.3390\/nu17101708"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Vemulapalli, V., and Shirwaikar Thomas, A. (2025). The Role of Vitamin D in Gastrointestinal Homeostasis and Gut Inflammation. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26073020"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Guan, R., Peng, J., Gu, Q., Xu, J., Zhang, J., Adamu, H., Yang, Q., Wang, L., and Cao, G. (2026). The Gut-Kidney Axis in Chronic Kidney Disease: A Vicious Cycle of Microbial Dysbiosis and Uremic Toxin Accumulation. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1801912"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E., Budny, E., Saar, M., Wojtanowska, E., Jankowska, J., Marciszuk, S., Mazur, M., Rysz, J., and Franczyk, B. (2024). Does the Composition of Gut Microbiota Affect Chronic Kidney Disease? Molecular Mechanisms Contributed to Decreasing Glomerular Filtration Rate. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910429"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/tcmj.tcmj_293_24","article-title":"Gut-Derived Uremic Toxins and Cardiovascular Health in Chronic Kidney Disease","volume":"37","author":"Chen","year":"2025","journal-title":"Tzu Chi Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"123981","DOI":"10.1016\/j.lfs.2025.123981","article-title":"The Gut Microbiota and Cardiovascular Disease: Exploring the Role of Microbial Dysbiosis and Metabolites in Pathogenesis and Therapeutics","volume":"381","author":"Mohsenzadeh","year":"2025","journal-title":"Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/ckj\/sfaa121","article-title":"Serum Total Indoxyl Sulfate and Clinical Outcomes in Hemodialysis Patients: Results from the Japan Dialysis Outcomes and Practice Patterns Study","volume":"14","author":"Yamamoto","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ehf2.14566","article-title":"Predictive Value of Protein-bound Uremic Toxins for Heart Failure in Patients with Chronic Kidney Disease","volume":"11","author":"Zwaenepoel","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e70065","DOI":"10.1111\/bcpt.70065","article-title":"p-Cresol and p-Cresyl Sulphate Boost Oxidative Stress: A Systematic Review of Recent Evidence","volume":"137","author":"Renaldi","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Lin, C.-J., Wu, V., Wu, P.-C., and Wu, C.-J. (2015). Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132589"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/ndt\/gfab004","article-title":"Free p -Cresyl Sulfate Shows the Highest Association with Cardiovascular Outcome in Chronic Kidney Disease","volume":"36","author":"Glorieux","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Chern, Y.-B., Chia, K.L., Liu, C.-H., Lin, Y.-L., Tsai, J.-P., and Hsu, B.-G. (2025). Serum P-Cresyl Sulfate Is Independently Associated with Aortic Stiffness in Non-Dialysis Chronic Kidney Disease Patients. Life, 15.","DOI":"10.3390\/life15071116"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"114917","DOI":"10.1016\/j.fct.2024.114917","article-title":"Indole-3-Acetic Acid Exposure Leads to Cardiovascular Inflammation and Fibrosis in Chronic Kidney Disease Rat Model","volume":"192","author":"Nayak","year":"2024","journal-title":"Food Chem. Toxicol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"102115","DOI":"10.1016\/j.redox.2021.102115","article-title":"Gut Microbiota Dependent Trimethylamine N-Oxide Aggravates Angiotensin II\u2013Induced Hypertension","volume":"46","author":"Jiang","year":"2021","journal-title":"Redox Biol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Canyelles, M., Borr\u00e0s, C., Rotllan, N., Tondo, M., Escol\u00e0-Gil, J.C., and Blanco-Vaca, F. (2023). Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24031940"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jcmm.13307","article-title":"Circulating Trimethylamine N-oxide and the Risk of Cardiovascular Diseases: A Systematic Review and Meta-analysis of 11 Prospective Cohort Studies","volume":"22","author":"Qi","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/ajcn\/nqac278","article-title":"The Association between TMAO, CMPF, and Clinical Outcomes in Advanced Chronic Kidney Disease: Results from the European QUALity (EQUAL) Study","volume":"116","author":"Dai","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ma, L., Fu, G., Liu, R., Zhou, F., Dong, S., Zhou, Y., Lou, J., and Wang, X. (2023). Phenylacetyl Glutamine: A Novel Biomarker for Stroke Recurrence Warning. BMC Neurol., 23.","DOI":"10.1186\/s12883-023-03118-5"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e70024","DOI":"10.1002\/cph4.70024","article-title":"Microbiota in Gut-Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease","volume":"15","author":"Kondapalli","year":"2025","journal-title":"Compr. Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zhang, S., Tang, S., Liu, Y., Xue, B., Xie, Q., Zhao, L., and Yuan, H. (2025). Protein-Bound Uremic Toxins as Therapeutic Targets for Cardiovascular, Kidney, and Metabolic Disorders. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1500336"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e5799","DOI":"10.1097\/MD.0000000000005799","article-title":"Free and Total P-Cresol Sulfate Levels and Infectious Hospitalizations in Hemodialysis Patients in CHOICE and HEMO","volume":"96","author":"Banerjee","year":"2017","journal-title":"Medicine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s11255-022-03137-0","article-title":"Indole-3-Acetic Acid Correlates with Monocyte-to-High-Density Lipoprotein (HDL) Ratio (MHR) in Chronic Kidney Disease Patients","volume":"54","author":"Cernaro","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"936","DOI":"10.17305\/bb.2023.8893","article-title":"The Roles of Trimethylamine-N-Oxide in Atherosclerosis and Its Potential Therapeutic Aspect: A Literature Review","volume":"23","author":"Oktaviono","year":"2023","journal-title":"Biomol. Biomed."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Thakur, D., and Harmer, M.J. (2026). Circulating Short-Chain Fatty Acid Levels in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Nutrients, 18.","DOI":"10.3390\/nu18091440"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.aed.2025.11.015","article-title":"Harnessing Microbiome Therapy to Treat Metabolic Syndrome","volume":"13","author":"Govindarajan","year":"2026","journal-title":"AACE Endocrinol. Diabetes"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"116968","DOI":"10.1016\/j.intimp.2026.116968","article-title":"Small but Mighty: The Human Mycobiome as an Immunopharmacological Regulator of Inflammation and Autoimmunity","volume":"185","author":"Ahmad","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"104889","DOI":"10.1016\/j.jpet.2026.104889","article-title":"The Roles of Free-Fatty Acid Receptors in the Pathophysiology of Renal Disorders","volume":"393","author":"Karmokar","year":"2026","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Szrejder, M., and Piwkowska, A. (2025). Gut Microbiome-Derived Short-Chain Fatty Acids in Glomerular Protection and Modulation of Chronic Kidney Disease Progression. Nutrients, 17.","DOI":"10.3390\/nu17172904"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1042\/CS20190171","article-title":"Quantitative Reduction in Short-Chain Fatty Acids, Especially Butyrate, Contributes to the Progression of Chronic Kidney Disease","volume":"133","author":"Wang","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2217\/fmb-2017-0059","article-title":"Short-Chain Fatty Acids: A Link Between Prebiotics And Microbiota In Chronic Kidney Disease","volume":"12","author":"Esgalhado","year":"2017","journal-title":"Future Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wakino, S., Hasegawa, K., Tamaki, M., Minato, M., and Inagaki, T. (2025). Kidney-Gut Axis in Chronic Kidney Disease: Therapeutic Perspectives from Microbiota Modulation and Nutrition. Nutrients, 17.","DOI":"10.3390\/nu17121961"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40168-025-02089-8","article-title":"Life-Long Microbiome Rejuvenation Improves Intestinal Barrier Function and Inflammaging in Mice","volume":"13","author":"Sommer","year":"2025","journal-title":"Microbiome"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Yang, Y., Mihajlovic, M., and Masereeuw, R. (2023). Protein-Bound Uremic Toxins in Senescence and Kidney Fibrosis. Biomedicines, 11.","DOI":"10.20944\/preprints202308.0733.v1"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Tsuji, K., Uchida, N., Nakanoh, H., Fukushima, K., Haraguchi, S., Kitamura, S., and Wada, J. (2024). The Gut\u2013Kidney Axis in Chronic Kidney Diseases. Diagnostics, 15.","DOI":"10.20944\/preprints202411.1338.v1"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Upadhyay, P., Suhail, A., Khanal, P., and Kumar, S. (2025). Mechanistic Insights and Biomarker Discovery in Immune Cell Aging and Age-Associated Diseases. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1637191"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.biochi.2025.10.008","article-title":"Premature Aging in Chronic Kidney Disease: Decoding Senescence Biomarkers and Therapeutic Opportunities","volume":"240","author":"Braga","year":"2025","journal-title":"Biochimie"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/eji.201343921","article-title":"Circulating Mitochondrial DNA Increases with Age and Is a Familiar Trait: Implications for \u201cInflamm-aging\u201d","volume":"44","author":"Pinti","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhao, D., Yan, Z., Yu, Y., Zhang, Y., and Luan, Z. (2026). From Mechanisms to Therapies: Exploiting Epigenetic and Post-Translational Modifications of Mitochondrial Quality Control in Diabetic Kidney Disease. Front. Endocrinol., 17.","DOI":"10.3389\/fendo.2026.1821507"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"123999","DOI":"10.1016\/j.lfs.2025.123999","article-title":"Diabetic Kidney Disease and Aging: Focus on Gut Microbiota","volume":"381","author":"Rong","year":"2025","journal-title":"Life Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e70031","DOI":"10.1002\/mnfr.70031","article-title":"Trimethylamine N -Oxide Plasma Levels Following Red Meat and Cod Fish Intake: A Pilot Crossover Trial in Hemodialysis Patients","volume":"69","author":"Santana","year":"2025","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Sun, M., Fang, Y., Zheng, J., Shi, G., Guo, J., Zhang, X., and Zhang, R. (2024). Role of Symbiotic Microbiota Dysbiosis in the Progression of Chronic Kidney Disease Accompanied with Vascular Calcification. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1306125"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"110139","DOI":"10.1016\/j.jnutbio.2025.110139","article-title":"Association of Poor Vitamin K Status with Inflammation and Gut Microbiota in Hemodialysis Patients: A Cross-Sectional Study","volume":"148","author":"Lima","year":"2026","journal-title":"J. Nutr. Biochem."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Palamar, M., Grosu Radulescu, I.D., Tanasescu, M.D., Sircuta, A., and Bob, F. (2025). Vascular Calcification in Chronic Kidney Disease and Hemodialysis: Pathophysiological Mechanisms and Emerging Biomarkers. Medicina, 61.","DOI":"10.3390\/medicina61122169"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Neofytou, I.E., Stamou, A., Demopoulos, A., Roumeliotis, S., Zebekakis, P., Liakopoulos, V., Stamellou, E., and Dounousi, E. (2024). Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn. Nutrients, 16.","DOI":"10.3390\/nu16121798"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11906-023-01263-3","article-title":"Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension","volume":"25","author":"Vallianou","year":"2023","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"32910","DOI":"10.1038\/s41598-025-17751-2","article-title":"Gut Dysbiosis and Brain Microhemorrhages in Young vs. Aged Mice with Chronic Kidney Disease","volume":"15","author":"Zhao","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"115068","DOI":"10.1016\/j.physbeh.2025.115068","article-title":"Gut Microbiome Mediates the Causal Relationship between Chronic Kidney Disease and Cognitive Dysfunction: A Mendelian Randomization Study","volume":"301","author":"Zhou","year":"2025","journal-title":"Physiol. Behav."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.chom.2025.08.014","article-title":"Gut-Microbiota-Derived Indole Sulfate Promotes Heart Failure in Chronic Kidney Disease","volume":"33","author":"Zhang","year":"2025","journal-title":"Cell Host Microbe"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e03101-22","DOI":"10.1128\/spectrum.03101-22","article-title":"Dysbiosis of Gut Microbiota Contributes to Uremic Cardiomyopathy via Induction of IFN\u03b3-Producing CD4+ T Cells Expansion","volume":"11","author":"Han","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Bakinowska, E., Olejnik-Wojciechowska, J., Kie\u0142bowski, K., Skoryk, A., and Pawlik, A. (2024). Pathogenesis of Sarcopenia in Chronic Kidney Disease\u2014The Role of Inflammation, Metabolic Dysregulation, Gut Dysbiosis, and microRNA. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158474"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12938\/bmfh.2024-048","article-title":"Verification of an Alteration in the Gut Microbiota That Increases Nutritional Risk in Patients on Hemodialysis","volume":"44","author":"Fukuhara","year":"2025","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Li, Z., Rasmussen, T.S., Rasmussen, M.L., Li, J., Henr\u00edquez Olgu\u00edn, C., Kot, W., Nielsen, D.S., and Jensen, T.E. (2019). The Gut Microbiome on a Periodized Low-Protein Diet Is Associated With Improved Metabolic Health. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00709"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.7150\/ijms.66451","article-title":"Effects of Low Protein Diet on Modulating Gut Microbiota in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of International Studies","volume":"18","author":"Hsu","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"37311","DOI":"10.31083\/IJVNR37311","article-title":"Low-Protein Calorie-Restriction Mitigates Diabetic Mice Kidney Injury via the Gut\u2013Kidney Axis","volume":"95","author":"Zhang","year":"2025","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2215\/CJN.0000000705","article-title":"Dietary Intake and Gut Microbiome in CKD","volume":"20","author":"Kemp","year":"2025","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hsu, B.-G., Tong, L.-X., Liou, H.-H., Wang, C.-H., and Lin, Y.-L. (2025). Associations of Increased Plant Protein Intake Ratio with Adherence of Low-Protein Diet, Acid-Base Status, and Body Composition in CKD Stage 3\u20135. Nutrients, 17.","DOI":"10.3390\/nu17162649"},{"key":"ref_87","first-page":"469","article-title":"A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome","volume":"43","author":"Shi","year":"2025","journal-title":"Cardiol. Clin."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Ranganathan, N., and Anteyi, E. (2022). The Role of Dietary Fiber and Gut Microbiome Modulation in Progression of Chronic Kidney Disease. Toxins, 14.","DOI":"10.3390\/toxins14030183"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1093\/ndt\/gfs132","article-title":"Essential Polyunsaturated Fatty Acids, Inflammation and Mortality in Dialysis Patients","volume":"27","author":"Huang","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2506810","DOI":"10.1080\/0886022X.2025.2506810","article-title":"Impact of Gut Microbiota in Chronic Kidney Disease: Natural Polyphenols as Beneficial Regulators","volume":"47","author":"Li","year":"2025","journal-title":"Ren. Fail."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s40620-020-00765-6","article-title":"Plant-Based Diets, Insulin Sensitivity and Inflammation in Elderly Men with Chronic Kidney Disease","volume":"33","author":"Xu","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.clnesp.2024.11.022","article-title":"The Associations between Nutrition and Circulating Gut Microbiota-Derived Uremic Toxins in Patients Undergoing Kidney Replacement Therapy: An Observational, Cross-Sectional Study","volume":"65","author":"Potrykus","year":"2025","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2341449","DOI":"10.1080\/19490976.2024.2341449","article-title":"Sweet, Bloody Consumption\u2014What We Eat and How It Affects Vascular Ageing, the BBB and Kidney Health in CKD","volume":"16","author":"Schwarz","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e14428","DOI":"10.1111\/1751-7915.14428","article-title":"Fermented Foods, Their Microbiome and Its Potential in Boosting Human Health","volume":"17","author":"Valentino","year":"2024","journal-title":"Microb. Biotechnol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12937-016-0127-3","article-title":"Association between Probiotic and Yogurt Consumption and Kidney Disease: Insights from NHANES","volume":"15","author":"Yacoub","year":"2015","journal-title":"Nutr. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"103772","DOI":"10.1016\/j.numecd.2024.10.010","article-title":"Milk and Yogurt Consumption and Its Association with Cardiometabolic Risk Factors in Patients with Type 2 Diabetes: The Fukuoka Diabetes Registry","volume":"35","author":"Yoshinari","year":"2025","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"10173","DOI":"10.1080\/10408398.2022.2077300","article-title":"Fermented Food: Should Patients with Cardiometabolic Diseases Go Back to an Early Neolithic Diet?","volume":"63","author":"Mafra","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_98","first-page":"500","article-title":"The Effects of Prebiotic Dietary Fibers, Probiotics, and Synbiotics on Gut Permeability and Immunity: A Systematic Review","volume":"50","author":"Hosseini","year":"2025","journal-title":"Iran. J. Med. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ekir.2023.12.017","article-title":"Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study","volume":"9","author":"Sohn","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Calder\u00f3n-Ju\u00e1rez, M., Saavedra-Fuentes, N., Del Castillo-Loreto, K.G., Castillo-Salinas, J.C., and Lerma, C. (2024). Diet Supplementation with Ketoanalogues, Inulin, and Calcium Citrate in Chronic Kidney Disease: A Retrospective Cohort. Life, 14.","DOI":"10.3390\/life14121638"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2416609","DOI":"10.1080\/0886022X.2024.2416609","article-title":"Effects of Resistant Starch Supplementation on Renal Function and Inflammatory Markers in Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials","volume":"46","author":"Zhang","year":"2024","journal-title":"Ren. Fail."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.jrn.2024.09.005","article-title":"Effects of High Amylose-Resistant Starch on Gut Microbiota and Uremic Toxin Levels in Patients With Stage-G3a-G4 Chronic Kidney Disease: A Randomized Trial","volume":"35","author":"Headley","year":"2025","journal-title":"J. Ren. Nutr."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Poesen, R., Evenepoel, P., De Loor, H., Delcour, J.A., Courtin, C.M., Kuypers, D., Augustijns, P., Verbeke, K., and Meijers, B. (2016). The Influence of Prebiotic Arabinoxylan Oligosaccharides on Microbiota Derived Uremic Retention Solutes in Patients with Chronic Kidney Disease: A Randomized Controlled Trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153893"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3747\/pdi.2014.00015","article-title":"Effects of Fructo-Oligosaccharide Supplementation on Constipation in Elderly Continuous Ambulatory Peritoneal Dialysis Patients","volume":"36","author":"Meksawan","year":"2016","journal-title":"Perit. Dial. Int. J. Int. Soc. Perit. Dial."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1080\/10408398.2021.1996331","article-title":"Dietary Strategies for Gut-Derived Protein-Bound Uremic Toxins and Cardio-Metabolic Risk Factors in Chronic Kidney Disease: A Focus on Dietary Fibers","volume":"63","author":"Melekoglu","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Sheng, W., Ji, G., and Zhang, L. (2023). Immunomodulatory Effects of Inulin and Its Intestinal Metabolites. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1224092"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MNH.0000000000000961","article-title":"Oh, My Gut! New Insights on the Role of the Gastrointestinal Tract and the Gut Microbiome in Chronic Kidney Disease-Mineral and Bone Disorder","volume":"33","author":"Mirmohammadali","year":"2024","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Lai, S., Mazzaferro, S., Muscaritoli, M., Mastroluca, D., Testorio, M., Perrotta, A., Esposito, Y., Carta, M., Campagna, L., and Di Grado, M. (2020). Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters. Toxins, 12.","DOI":"10.3390\/toxins12060381"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e00061","DOI":"10.1097\/IN9.0000000000000061","article-title":"Aging Immunity: Unraveling the Complex Nexus of Diet, Gut Microbiome, and Immune Function","volume":"7","author":"Babakhani","year":"2025","journal-title":"Immunometabolism"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Anegkamol, W., Kamkang, P., Hunthai, S., Kaewwongse, M., Taweevisit, M., Chuaypen, N., Rattanachaisit, P., and Dissayabutra, T. (2023). The Usefulness of Resistant Maltodextrin and Chitosan Oligosaccharide in Management of Gut Leakage and Microbiota in Chronic Kidney Disease. Nutrients, 15.","DOI":"10.3390\/nu15153363"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Liu, C., Wang, J., Lei, L., Li, L., and Yuan, X. (2025). Gut Microbiota Therapy for Chronic Kidney Disease. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1660226"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00394-018-1785-z","article-title":"An Open-Label, Randomized, Placebo-Controlled Study on the Effectiveness of a Novel Probiotics Administration Protocol (ProbiotiCKD) in Patients with Mild Renal Insufficiency (Stage 3a of CKD)","volume":"58","author":"Simeoni","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","article-title":"Probiotic Supplementation in Diabetic Hemodialysis Patients Has Beneficial Metabolic Effects","volume":"91","author":"Soleimani","year":"2017","journal-title":"Kidney Int."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"De Mauri, A., Carrera, D., Bagnati, M., Rolla, R., Vidali, M., Chiarinotti, D., Pane, M., Amoruso, A., and Del Piano, M. (2022). Probiotics-Supplemented Low-Protein Diet for Microbiota Modulation in Patients with Advanced Chronic Kidney Disease (ProLowCKD): Results from a Placebo-Controlled Randomized Trial. Nutrients, 14.","DOI":"10.3390\/nu14081637"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.jrn.2017.04.004","article-title":"The Impact of Probiotic Soy Milk Consumption on Oxidative Stress Among Type 2 Diabetic Kidney Disease Patients: A Randomized Controlled Clinical Trial","volume":"27","author":"Miraghajani","year":"2017","journal-title":"J. Ren. Nutr."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.cmet.2021.06.014","article-title":"The Probiotic L. Casei Zhang Slows the Progression of Acute and Chronic Kidney Disease","volume":"33","author":"Zhu","year":"2021","journal-title":"Cell Metab."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1007\/s42770-024-01491-y","article-title":"Effects of Live and Pasteurized Forms of Lactobacillus Casei Zhang on Acute Kidney Injury and Chronic Renal Fibrosis","volume":"55","author":"Wang","year":"2024","journal-title":"Braz. J. Microbiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"27990","DOI":"10.1038\/s41598-025-12768-z","article-title":"Lacticaseibacillus Rhamnosus Attenuates Uremic Toxins in Patients with Nondialysis Chronic Kidney Disease through the Anti-Inflammatory Molecules","volume":"15","author":"Leelahavanichkul","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.foodres.2018.08.024","article-title":"Synbiotic Meal Decreases Uremic Toxins in Hemodialysis Individuals: A Placebo-Controlled Trial","volume":"116","author":"Lopes","year":"2019","journal-title":"Food Res. Int."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Kuskunov, T., Tilkiyan, E., Zdravkova, I., Valova, S., Boyanov, K., and Bivolarska, A. (2025). The Impact of a 10-Month Synbiotic Intake on eGFR, Uremic Toxins, Oxidative Stress, and Inflammatory Markers in Non-Dialysis Chronic Kidney Disease Patients: A Prospective, Non-Randomized, Placebo-Controlled Study. Medicina, 61.","DOI":"10.3390\/medicina61071199"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Mitrea, L., Medeleanu, M., Pop, C.-R., Rotar, A.-M., and Vodnar, D.-C. (2023). Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies. Toxins, 15.","DOI":"10.3390\/toxins15090548"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Favero, C., Giordano, L., Mihaila, S.M., Masereeuw, R., Ortiz, A., and Sanchez-Ni\u00f1o, M.D. (2022). Postbiotics and Kidney Disease. Toxins, 14.","DOI":"10.3390\/toxins14090623"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00284-022-02783-y","article-title":"Probiotics and Their Metabolites Reduce Oxidative Stress in Middle-Aged Mice","volume":"79","author":"Lin","year":"2022","journal-title":"Curr. Microbiol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12223-025-01253-9","article-title":"Native Potential Probiotics and Postbiotics Improve the Gut-Kidney Axis by the Modulation of Autophagy Signaling Pathway","volume":"71","author":"Jouriani","year":"2025","journal-title":"Folia Microbiol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Osman, A., El-Gazzar, N., Almanaa, T.N., El-Hadary, A., and Sitohy, M. (2021). Lipolytic Postbiotic from Lactobacillus Paracasei Manages Metabolic Syndrome in Albino Wistar Rats. Molecules, 26.","DOI":"10.3390\/molecules26020472"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2213112","DOI":"10.1080\/20002297.2023.2213112","article-title":"The Interplay between Oral Microbiota, Gut Microbiota and Systematic Diseases","volume":"15","author":"Tan","year":"2023","journal-title":"J. Oral Microbiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e19492","DOI":"10.7717\/peerj.19492","article-title":"Exploring the Outcomes of Non-Surgical Periodontal Therapy in Modulating Periodontal Parameters, Renal Function, and Inflammatory Biomarkers in Chronic Kidney Disease Patients with Periodontitis","volume":"13","author":"Rajaratinam","year":"2025","journal-title":"PeerJ"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Basilicata, M., Pieri, M., Marrone, G., Nicolai, E., Di Lauro, M., Paolino, V., Tomassetti, F., Vivarini, I., Bollero, P., and Bernardini, S. (2023). Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases. Metabolites, 13.","DOI":"10.3390\/metabo13080889"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.jrn.2018.08.008","article-title":"Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis","volume":"29","author":"McFarlane","year":"2019","journal-title":"J. Ren. Nutr."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.jrn.2021.08.005","article-title":"Biotic Supplements in Patients With Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials","volume":"32","author":"Liu","year":"2022","journal-title":"J. Ren. Nutr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.jrn.2022.04.001","article-title":"Probiotics, Prebiotics, and Synbiotics for Patients on Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"33","author":"Chen","year":"2023","journal-title":"J. Ren. Nutr."},{"key":"ref_133","first-page":"CD013631","article-title":"Synbiotics, Prebiotics and Probiotics for People with Chronic Kidney Disease","volume":"2023","author":"Cooper","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Cedillo-Flores, R., Cuevas-Budhart, M.A., Cavero-Redondo, I., Kappes, M., \u00c1vila-D\u00edaz, M., and Paniagua, R. (2025). Impact of Gut Microbiome Modulation on Uremic Toxin Reduction in Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. Nutrients, 17.","DOI":"10.1101\/2025.02.21.25322662"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.clinthera.2020.12.021","article-title":"Effect of Probiotic, Prebiotic, and Synbiotic Supplementation on Cardiometabolic and Oxidative Stress Parameters in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis","volume":"43","author":"Bakhtiary","year":"2021","journal-title":"Clin. Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/0127724344308638240530065552","article-title":"Harnessing the Power of Probiotics: Boosting Immunity and Safeguarding against Various Diseases and Infections","volume":"20","author":"Singh","year":"2025","journal-title":"Recent Adv. Anti-Infect. Drug Discov."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Zhang, J., Ren, X., Li, B., Zhao, Z., Li, S., and Zhai, W. (2025). Fecal Microbiota Transplantation Is a Promising Therapy for Kidney Diseases. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1628722"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.7150\/thno.56598","article-title":"GPR43 Deficiency Protects against Podocyte Insulin Resistance in Diabetic Nephropathy through the Restoration of AMPK\u03b1 Activity","volume":"11","author":"Lu","year":"2021","journal-title":"Theranostics"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Bastos, R.M.C., Simpl\u00edcio-Filho, A., S\u00e1vio-Silva, C., Oliveira, L.F.V., Cruz, G.N.F., Sousa, E.H., Noronha, I.L., Mangueira, C.L.P., Quaglierini-Ribeiro, H., and Josefi-Rocha, G.R. (2022). Fecal Microbiota Transplant in a Pre-Clinical Model of Type 2 Diabetes Mellitus, Obesity and Diabetic Kidney Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073842"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Arteaga-Muller, G.Y., Flores-Trevi\u00f1o, S., Bocanegra-Ibarias, P., Robles-Espino, D., Garza-Gonz\u00e1lez, E., Fabela-Valdez, G.C., and Camacho-Ortiz, A. (2024). Changes in the Progression of Chronic Kidney Disease in Patients Undergoing Fecal Microbiota Transplantation. Nutrients, 16.","DOI":"10.3390\/nu16081109"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1080\/0886022X.2021.1936038","article-title":"Alleviation of Refractory IgA Nephropathy by Intensive Fecal Microbiota Transplantation: The First Case Reports","volume":"43","author":"Zhao","year":"2021","journal-title":"Ren. Fail."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13730-020-00560-z","article-title":"Fecal Microbiota Transplantation for Membranous Nephropathy","volume":"10","author":"Zhou","year":"2021","journal-title":"CEN Case Rep."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Zhi, W., Yuan, X., Song, W., Jin, G., and Li, Y. (2022). Fecal Microbiota Transplantation May Represent a Good Approach for Patients with Focal Segmental Glomerulosclerosis: A Brief Report. J. Clin. Med., 11.","DOI":"10.3390\/jcm11226700"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Huang, H.-W., Kuo, T.-C., Lee, Y.-J., and Chen, M.-J. (2025). Multi-Omics Analysis Reveals the Efficacy of Two Probiotic Strains in Managing Feline Chronic Kidney Disease through Gut Microbiome and Host Metabolome. Front. Vet. Sci., 12.","DOI":"10.3389\/fvets.2025.1590388"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2531202","DOI":"10.1080\/19490976.2025.2531202","article-title":"A Specifically Designed Multi-Biotic Reduces Uremic Toxin Generation and Improves Kidney Function","volume":"17","author":"Beau","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.14336\/AD.2023.0325","article-title":"Potential Effects of Akkermansia Muciniphila in Aging and Aging-Related Diseases: Current Evidence and Perspectives","volume":"14","author":"Zeng","year":"2023","journal-title":"Aging Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41392-024-01913-1","article-title":"Targeting Lactobacillus Johnsonii to Reverse Chronic Kidney Disease","volume":"9","author":"Miao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41581-022-00647-z","article-title":"Gut Microbiome Studies in CKD: Opportunities, Pitfalls and Therapeutic Potential","volume":"19","author":"Krukowski","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Luqman, A., Hassan, A., Ullah, M., Naseem, S., Ullah, M., Zhang, L., Din, A.U., Ullah, K., Ahmad, W., and Wang, G. (2024). Role of the Intestinal Microbiome and Its Therapeutic Intervention in Cardiovascular Disorder. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1321395"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/13\/1171\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T01:05:20Z","timestamp":1782695120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/13\/1171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":149,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cells15131171"],"URL":"https:\/\/doi.org\/10.3390\/cells15131171","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]}}}